AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

AMLODIPINE/ HYDROCHLOROTHIAZIDE/VALSARTAN

9 registrations across 1 African market— 9 active

Markets with AMLODIPINE/ HYDROCHLOROTHIAZIDE/VALSARTAN

Recent registrations

Brand / ProductMarketHolderStatusExpires
AMLO VH
comprimé / 10 mg / 160 mg / 25 mg
🇸🇳SenegalGENERIC HEALTH CAREactive
AMLO VH
comprimé / 25mg / 5 mg / 160 mg
🇸🇳SenegalGENERIC HEALTH CAREactive
AMLO VH
comprimé / 160 mg / 25 mg / 5 mg
🇸🇳SenegalGENERIC HEALTH CAREactive
AMLO VH
comprimé / 12.5 mg / 160 mg / 5 mg
🇸🇳SenegalGENERIC HEALTH CAREactive
EXFORGE HTC
comprimé / 10 mg /160 mg /12,5 mg
🇸🇳SenegalNOVARTIS PHARMAactive
EXFORGE HTC
comprimé / 5 mg /160 mg /25 mg
🇸🇳SenegalNOVARTIS PHARMAactive
EXFORGE HTC
comprimé / 5 mg /160 mg /12,5 mg
🇸🇳SenegalNOVARTIS PHARMAactive
AMLO VH
comprimé / 25mg / 5 mg / 160 mg
🇸🇳SenegalGENERIC HEALTH CAREactive
AMLO VH
comprimé / 10 mg / 12.5 mg / 160 mg
🇸🇳SenegalGENERIC HEALTH CAREactive

AMLODIPINE/ HYDROCHLOROTHIAZIDE/VALSARTAN in Africa — Regulatory Overview

AMLODIPINE/ HYDROCHLOROTHIAZIDE/VALSARTAN is registered across 1 African markets with 9 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Senegal. AfricaRegulatory refreshes this data daily from official government sources.

Of the 9 registrations, 9 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.